TruPlan Computed Tomography (CT) Imaging Software vs Tempus ECG-AF
AI Verdict
Choose TruPlan Computed Tomography (CT) Imaging Software if…
Choose TruPlan Computed Tomography (CT) Imaging Software if your cardiology team requires advanced 3D visualization and precise pre-procedural planning for Left Atrial Appendage Closure (LAAC) procedures. This tool is ideal for optimizing surgical strategies, defining LAA landing zones, and conducting post-procedural follow-up with comprehensive anatomical assessment.
View TruPlan Computed Tomography (CT) Imaging Software →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your practice aims to proactively identify older patients at elevated risk of developing new-onset atrial fibrillation within the next year. This AI-powered ECG analysis is best suited for screening patients aged 65 or older without a prior AF diagnosis, enabling earlier intervention and personalized management strategies.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | TruPlan Computed Tomography (CT) Imaging Software | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Standalone software onto user's desktop or laptop, or as a server within hospital infrastructure with a thick-client software on multiple users' desktop or laptop computers. It can integrate with PACS using standard DICOM protocols. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TruPlan Computed Tomography (CT) Imaging SoftwareTruPlan offers a highly interactive and visual user experience with features like comprehensive 3D anatomical assessment, segmentation, sculpting, and TEE simulation for complex procedural planning. Its design is focused on enhancing workflow for specific interventional procedures, with explicit mentions of intuitive controls and ease of use.
Clinical Value
TieBoth tools offer significant clinical value in different areas. TruPlan directly aids in the planning and execution of complex Left Atrial Appendage Closure (LAAC) procedures, potentially improving procedural outcomes and efficiency. Tempus ECG-AF provides crucial early risk identification for Atrial Fibrillation (AF) in a broad patient population, enabling proactive management and stroke prevention.
Pricing & Value
Tempus ECG-AFTempus ECG-AF provides clear transparency regarding its financial value proposition by explicitly stating CMS reimbursement codes (CPT 0764T and CPT 0765T) and a Medicare rate of $128.90, effective January 1, 2025. TruPlan, in contrast, only states 'contact for pricing,' offering no public information on its cost or potential reimbursement.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for legal and secure data handling in healthcare enterprises. While TruPlan is FDA-cleared and integrates with existing systems, the lack of explicit HIPAA compliance and BAA for the product itself could pose a barrier for enterprise adoption.
Innovation
TieBoth tools demonstrate significant innovation in their respective applications of AI. TruPlan pushes boundaries with its advanced 3D visualization, automated segmentation, and simulation capabilities for complex interventional planning. Tempus ECG-AF is innovative as the first FDA-cleared AI-based algorithm for AF risk prediction from standard ECGs, enabling widespread proactive identification.
Support & Docs
TieBoth companies appear to offer dedicated customer support. Circle Cardiovascular Imaging (Tool A) highlights a 'world class support and clinical team' with 'Real People, Real Time Support' and training programs. Tempus AI (Tool B) provides specific contact information for their Cardiology Support team via email and phone. Without more detailed comparative metrics on the depth of documentation or responsiveness, it is difficult to distinguish a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | TruPlan Computed Tomography (CT) Imaging Software | Tempus ECG-AF |
|---|---|---|
| Tool Name | TruPlan Computed Tomography (CT) Imaging Software | Tempus ECG-AF |
| Company | Circle Cardiovascular Imaging | Tempus AI, Inc. |
| Description | AI-powered medical device for comprehensive visualization and planning of Left Atrial Appendage Closure (LAAC) procedures. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Primary Clinical Focus | Left Atrial Appendage Closure (LAAC) procedures | Identification of patients at risk of developing Atrial Fibrillation/flutter (AF) |
| Target Patient Population | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Key Feature Example | Automated LAA landing zone definition using machine learning | AI-based algorithm for 12-lead ECG analysis |
Videos
Demos, reviews, and walkthroughs featuring TruPlan Computed Tomography (CT) Imaging Software and Tempus ECG-AF.